Literature DB >> 12496947

Flattening the corticosterone rhythm attenuates 5-HT1A autoreceptor function in the rat: relevance for depression.

Melville M Leitch1, Colin D Ingram, Allan H Young, Richard McQuade, Sarah E Gartside.   

Abstract

Depression is associated with glucocorticoid abnormalities, in particular a flattening of the diurnal cortisol rhythm. Recent data suggest that an important factor in the aetiology of depression may be a deficit in the function and expression of 5-HT(1A) receptors, which has been reported in depressed patients. The present study assessed the possibility that this cortisol abnormality is causal in the 5-HT(1A) receptor deficits. First, a rat model of flattened glucocorticoid rhythm was developed. Controlled release corticosterone pellets implanted for 14 days flattened the corticosterone rhythm and maintained levels constant midway between the nadir and zenith levels observed in sham-operated rats. Secondly, using microdialysis to assess 5-HT release in the hippocampus, the inhibitory response to 8-OHDPAT was measured to determine the sensitivity of somatodendritic 5-HT(1A) autoreceptors. Corticosterone treatment was found to induce a significant attenuation in the response to 8-OHDPAT, indicating functional desensitization of somatodendritic 5-HT(1A) autoreceptors. There was no effect of corticosterone treatment on basal extracellular 5-HT levels. The data suggest that the glucocorticoid abnormalities associated with depression may impact on the functioning of 5-HT(1A) receptors in the brain. These findings suggest that resolution of cortisol abnormalities may be a valuable target for pharmacotherapy in the treatment of depression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12496947     DOI: 10.1038/sj.npp.1300016

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  24 in total

1.  The HPA axis modulates the CNS melanocortin control of liver triacylglyceride metabolism.

Authors:  Petra Wiedmer; Nilika Chaudhary; Michaela Rath; Chun-Xia Yi; Gayathri Ananthakrishnan; Rubén Nogueiras; Eva K Wirth; Henriette Kirchner; Ulrich Schweizer; Wenke Jonas; Christelle Veyrat-Durebex; Francoise Rohner-Jeanrenaud; Annette Schürmann; Hans-Georg Joost; Matthias H Tschöp; Diego Perez-Tilve
Journal:  Physiol Behav       Date:  2011-10-28

Review 2.  5-HT(1A) receptor function in major depressive disorder.

Authors:  Jonathan Savitz; Irwin Lucki; Wayne C Drevets
Journal:  Prog Neurobiol       Date:  2009-02-07       Impact factor: 11.685

3.  Effect of subchronic corticosterone administration on α2-adrenoceptor functionality in rat brain: an in vivo and in vitro study.

Authors:  Igor Horrillo; Jorge E Ortega; Rebeca Diez-Alarcia; Leyre Urigüen; J Javier Meana
Journal:  Psychopharmacology (Berl)       Date:  2016-09-04       Impact factor: 4.530

4.  Serotonin modulates the suppressive effects of corticosterone on proliferating progenitor cells in the dentate gyrus of the hippocampus in the adult rat.

Authors:  Guo-Jen Huang; Joe Herbert
Journal:  Neuropsychopharmacology       Date:  2005-02       Impact factor: 7.853

Review 5.  Epilepsy Associated Depression: An Update on Current Scenario, Suggested Mechanisms, and Opportunities.

Authors:  Tanveer Singh; Rajesh Kumar Goel
Journal:  Neurochem Res       Date:  2021-03-04       Impact factor: 3.996

6.  Cortisol awakening response and additive serotonergic genetic risk interactively predict depression in two samples: The 2019 Donald F. Klein Early Career Investigator Award Paper.

Authors:  Suzanne Vrshek-Schallhorn; Catherine B Stroud; Leah D Doane; Susan Mineka; Richard E Zinbarg; Eva E Redei; Michelle G Craske; Emma K Adam
Journal:  Depress Anxiety       Date:  2019-04-24       Impact factor: 6.505

7.  Elevated plasma corticosterone level and depressive behavior in experimental temporal lobe epilepsy.

Authors:  Andrey M Mazarati; Don Shin; Young Se Kwon; Anatol Bragin; Eduardo Pineda; Delia Tio; Anna N Taylor; Raman Sankar
Journal:  Neurobiol Dis       Date:  2009-03-11       Impact factor: 5.996

Review 8.  Corticosteroid-serotonin interactions in depression: a review of the human evidence.

Authors:  Richard J Porter; Peter Gallagher; Stuart Watson; Allan H Young
Journal:  Psychopharmacology (Berl)       Date:  2004-03-09       Impact factor: 4.530

9.  Effect of sub-chronic hydrocortisone on responses to amphetamine in normal male volunteers.

Authors:  Andrea J Hearn; Peter Gallagher; Bruce M Owen; Margaret S Smith; Stuart Watson; Allan H Young
Journal:  Psychopharmacology (Berl)       Date:  2003-09-23       Impact factor: 4.530

10.  Transient increase in alcohol self-administration following a period of chronic exposure to corticosterone.

Authors:  Joyce Besheer; Kristen R Fisher; Tessa G Lindsay; Reginald Cannady
Journal:  Neuropharmacology       Date:  2013-05-03       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.